Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50

COVID-19 vaccines driving a decoupling between infections and deaths

With the numbers of reported COVID-19 cases hitting their highest levels since January, Delta has led to a reevaluation of vaccines.

By Brian Buntz | August 10, 2021

COVID-19

[Image courtesy of CDC]

In the U.S., areas with low vaccination rates have seen an uptick in vaccinations, while authorities in many highly-vaccinated areas have recommended mask-wearing and similar COVID-19 policies.

While Delta has blunted COVID-19 vaccines’ ability to reduce transmission, vaccines remain effective at saving lives. During the peak of the prior wave, thousands of people died daily from the novel coronavirus. But now, with new cases surpassing 200,000 each day, death rates have only ticked up gradually in the U.S. as a whole. Deaths, however, have marched up considerably in states with low vaccination rates, such as Louisiana, Arkansas and Florida. In such areas, COVID-19 hospitalizations are roughly in line with summer 2020 levels.

“There’s more of a decoupling” between the vaccinated and unvaccinated, said Dr. Monica Gandhi, a professor of medicine at the University of California, San Francisco, in a webinar last week from the Bay Area Council. “Hospitalizations are mainly among the unvaccinated.” The data illustrating the gulf is “quite clear,” Gandhi said.

While breakthrough infections in the vaccinated have grown more common in the Delta wave, the role of the unvaccinated in driving hospitalizations and death rates upward has elicited consternation from Dr. Anthony Fauci, chief medical advisor to President Biden.

“As we’ve said all along — this is fundamentally a pandemic among the unvaccinated,” Fauci said in an interview on NBC’s “Meet the Press.”

Just over half of the entire public is fully vaccinated, according to CDC.

Yet vaccinations are ticking up, and vaccine mandates are growing more common.

As many health authorities aim to reinstate mask mandates and other protections, some conservative politicians are calling for defiance. Kentucky senator Dr. Rand Paul. “It’s time for us to resist. They can’t arrest all of us,” Paul said in a recent video decrying lockdowns and other measures.

India, where the Delta variant first emerged, and the U.K. provide clues as to what is in store for the U.S. In the highly vaccinated U.K., COVID-19 infections began to drop sharply but later plateaued. Cases there now are about 5% higher than they were a week ago. In India, cases have dropped considerably despite low vaccination rates there. In late July, the country hit the threshold of vaccinating 10% of its adult population. By contrast, the U.K. has vaccinated more than 90% of its adult population.

 


Filed Under: Infectious Disease
Tagged With: coronavirus, covid-19, COVID-19 vaccine, COVID-19 vaccine trial, COVID-19 vaccines
 

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

JYNNEOS vaccine
Jynneos vaccine: The best weapon against monkeypox?
Axcella
Axcella touts positive results from Phase 2a long COVID study
monkeypox
3 critical monkeypox vaccine questions 
Moderna in the Drug Discovery & Development Pharma 50
Moderna inks deal with US for up to 300M omicron boosters

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Medtech100 Index
  • Medical Design Sourcing
  • Subscribe to our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • R&D 100 Awards
  • Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50